Vivos Inc. (RDGL)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Michael K. Korenko Ph.D. | CEO, President & Director | 266.39k | -- | 1946 |
| Dr. Carlton M. Cadwell D.D.S. | Independent Chairman & Secretary | -- | -- | 1945 |
| Mr. Michael H. Pollack CPA | Chief Financial Officer | -- | -- | 1966 |
| Dr. David J. Swanberg M.S., P.E. | Chief Technical Manager | -- | -- | 1957 |
| LeeAnna D. Binder | Social Media & Marketing Manager | -- | -- | -- |
Vivos Inc.
- Sector:?
- Healthcare
- Industry:? Medical Devices
- Full Time Employees:?
- 1
Description
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
Corporate Governance
Upcoming Events
November 4, 2024 at 4:28 PM UTC - November 8, 2024 at 4:28 PM UTC
Vivos Inc. Earnings Date
Recent Events
December 22, 2023 at 12:00 AM UTC
253G2: Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular
December 5, 2023 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission